Stocks
Summit Therapeutics Sets November 14 FDA PDUFA Date for Ivonescimab
Summit Therapeutics has received a November 14 PDUFA date for its ivonescimab BLA. The company is also planning the HARMONi-3 PFS trial...
#stock news 2 articles
Stocks
Caliber CFO Jade Leung Departs After 11 Years; Rosales Named Acting Successor
Caliber (CWD) announced CFO Jade Leung will step down after 11 years. Michael Rosales has been appointed acting CFO, effective June 14,...